Unknown

Dataset Information

0

Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers.


ABSTRACT: Rhabdomyosarcoma is subclassified by the presence or absence of a recurrent chromosome translocation that fuses the FOXO1 and PAX3 or PAX7 genes. The fusion protein (FOXO1-PAX3/7) retains both binding domains and becomes a novel and potent transcriptional regulator in rhabdomyosarcoma subtypes. Many studies have characterized and integrated genomic, transcriptomic, and epigenomic differences among rhabdomyosarcoma subtypes that contain the FOXO1-PAX3/7 gene fusion and those that do not; however, few investigations have investigated how gene co-expression networks are altered by FOXO1-PAX3/7. Although transcriptional data offer insight into one level of functional regulation, gene co-expression networks have the potential to identify biological interactions and pathways that underpin oncogenesis and tumorigenicity. Thus, we examined gene co-expression networks for rhabdomyosarcoma that were FOXO1-PAX3 positive, FOXO1-PAX7 positive, or fusion negative. Gene co-expression networks were mined using local maximum Quasi-Clique Merger (lmQCM) and analyzed for co-expression differences among rhabdomyosarcoma subtypes. This analysis observed 41 co-expression modules that were shared between fusion negative and positive samples, of which 17/41 showed significant up- or down-regulation in respect to fusion status. Fusion positive and negative rhabdomyosarcoma showed differing modularity of co-expression networks with fusion negative (n = 109) having significantly more individual modules than fusion positive (n = 53). Subsequent analysis of gene co-expression networks for PAX3 and PAX7 type fusions observed 17/53 were differentially expressed between the two subtypes. Gene list enrichment analysis found that gene ontology terms were poorly matched with biological processes and molecular function for most co-expression modules identified in this study; however, co-expressed modules were frequently localized to cytobands on chromosomes 8 and 11. Overall, we observed substantial restructuring of co-expression networks relative to fusion status and fusion type in rhabdomyosarcoma and identified previously overlooked genes and pathways that may be targeted in this pernicious disease.

SUBMITTER: Helm BR 

PROVIDER: S-EPMC6770752 | biostudies-other | 2019 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications


Rhabdomyosarcoma is subclassified by the presence or absence of a recurrent chromosome translocation that fuses the <i>FOXO1</i> and <i>PAX3</i> or <i>PAX7</i> genes. The fusion protein (FOXO1-PAX3/7) retains both binding domains and becomes a novel and potent transcriptional regulator in rhabdomyosarcoma subtypes. Many studies have characterized and integrated genomic, transcriptomic, and epigenomic differences among rhabdomyosarcoma subtypes that contain the <i>FOXO1-PAX3/7</i> gene fusion and  ...[more]

Similar Datasets

| S-EPMC9924292 | biostudies-literature
| S-EPMC6389798 | biostudies-literature
| S-EPMC7917223 | biostudies-literature
| S-EPMC8016302 | biostudies-literature
| S-EPMC5560700 | biostudies-other
| S-EPMC4610152 | biostudies-literature
| S-EPMC8337009 | biostudies-literature
| S-EPMC10691702 | biostudies-literature
| S-EPMC8317122 | biostudies-literature
| S-EPMC4108274 | biostudies-literature